Skip to main content
. 2021 Aug 20;27:480–493.

Table 1. An overview of the different categories of drugs that are administered as ocular drops for maintaining IOP levels by the clinicians.

Category Example Mode of Action Observations
Cholinergic drugs
Pilocarpene
Increase TM outflow by causing the ciliary muscles to contract
Effective but causes side effects like dim vision
α-adrenergic receptor agonists
Brimonidine
Decrease AH production, and increase outflow via uveal sclera route
Allergic reaction is prominent
β-Adrenergic receptor antagonists (β-blockers)
Levobunolol, Timonol
Reduce AH inflow, by inhibiting its production in the ciliary body
Rare systemic effects such as bradycardia and fatigue
Prostaglandin analogs
Latanoprost, Tafluprost, Bimatoprost
Causes ECM morphogenesis via action of MMP’s, increases outflow facility via uveal sclera pathway
First choice of clinicians, least side effects
Carbonic anhydrase inhibitors Brinzolamide, Dorzolamide Decrease AH production Oral administration is more efficient butcauses side effects such as paresthesia of the hands and feet